These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 3770260)
1. Topical minoxidil useful in 18% of patients with androgenetic alopecia: a study of 430 cases. Tosti A Dermatologica; 1986; 173(3):136-8. PubMed ID: 3770260 [TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. Olsen EA; Weiner MS; Amara IA; DeLong ER J Am Acad Dermatol; 1990 Apr; 22(4):643-6. PubMed ID: 2180995 [TBL] [Abstract][Full Text] [Related]
4. Topical minoxidil therapy for androgenetic alopecia. A 30-month study. Koperski JA; Orenberg EK; Wilkinson DI Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717 [TBL] [Abstract][Full Text] [Related]
5. Topical minoxidil: review of efficacy and safety. Katz HI Cutis; 1989 Jan; 43(1):94-8. PubMed ID: 2644080 [TBL] [Abstract][Full Text] [Related]
6. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia. Stamatas GN; Wu J; Pappas A; Mirmirani P; McCormick TS; Cooper KD; Consolo M; Schastnaya J; Ozerov IV; Aliper A; Zhavoronkov A Cell Cycle; 2017; 16(17):1578-1584. PubMed ID: 28594262 [TBL] [Abstract][Full Text] [Related]
8. Topical minoxidil for hair regrowth. Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289 [TBL] [Abstract][Full Text] [Related]
9. Use of topical minoxidil therapy for androgenetic alopecia in women. Jacobs JP; Szpunar CA; Warner ML Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725 [TBL] [Abstract][Full Text] [Related]
10. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia. Roberts J; Desai N; McCoy J; Goren A Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771 [TBL] [Abstract][Full Text] [Related]
11. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia. Dhurat R; Chitallia J; May TW; Jayaraaman AM; Madhukara J; Anandan S; Vaidya P; Klenk A Skin Pharmacol Physiol; 2017; 30(6):298-305. PubMed ID: 29055953 [TBL] [Abstract][Full Text] [Related]
12. Diffuse hypertrichosis during treatment with 5% topical minoxidil. Peluso AM; Misciali C; Vincenzi C; Tosti A Br J Dermatol; 1997 Jan; 136(1):118-20. PubMed ID: 9039309 [TBL] [Abstract][Full Text] [Related]
13. A Comparative Study between the Efficacy and Safety of 5% Minoxidil Solution and 5% Minoxidil Milky Lotion in the Treatment of Male Androgenic Alopecia. Thuangtong R; Thanomkitti K; Suvanasuthi S J Med Assoc Thai; 2017 Jan; 100(1):70-7. PubMed ID: 29911772 [TBL] [Abstract][Full Text] [Related]